Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Alzheimer's Disease

  Free Subscription


3 Acta Neuropathol
6 Alzheimers Dement
1 Biol Psychiatry
1 BMC Neurol
3 Brain Res
1 Dement Geriatr Cogn Disord
20 J Alzheimers Dis
2 J Neurol Neurosurg Psychiatry
1 J Neurosci
2 Nat Rev Neurol
2 Nature
2 Neurobiol Aging
2 Neurology
2 Neurosci Lett
1 Neuroscience
2 PLoS One
1 Proc Natl Acad Sci U S A
2 Science

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Acta Neuropathol

  1. BALUSU S, De Strooper B
    The necroptosis cell death pathway drives neurodegeneration in Alzheimer's disease.
    Acta Neuropathol. 2024;147:96.
    PubMed         Abstract available

  2. GAO F, Zhang M, Wang Q, Ni M, et al
    Associations of CSF BACE1 with amyloid pathology, neurodegeneration, and cognition in Alzheimer's disease.
    Acta Neuropathol. 2024;147:97.
    PubMed         Abstract available

  3. SARKANY B, David C, Hortobagyi T, Gombas P, et al
    Early and selective localization of tau filaments to glutamatergic subcellular domains within the human anterodorsal thalamus.
    Acta Neuropathol. 2024;147:98.
    PubMed         Abstract available

    Alzheimers Dement

  4. OVEISGHARAN S, Yu L, de Paiva Lopes K, Tasaki S, et al
    Proteins linking APOE varepsilon4 with Alzheimer's disease.
    Alzheimers Dement. 2024 Jun 10. doi: 10.1002/alz.13867.
    PubMed         Abstract available

  5. YEW PY, Devera R, Liang Y, Khalifa RAE, et al
    Unraveling the multiple chronic conditions patterns among people with Alzheimer's disease and related dementia: A machine learning approach to incorporate synergistic interactions.
    Alzheimers Dement. 2024 Jun 11. doi: 10.1002/alz.13923.
    PubMed         Abstract available

  6. LEE JK, Raghavan S, Christenson LR, Frank RD, et al
    Longitudinal associations of reproductive factors and exogeneous estrogens with neuroimaging biomarkers of Alzheimer's disease and cerebrovascular disease.
    Alzheimers Dement. 2024 Jun 11. doi: 10.1002/alz.13890.
    PubMed         Abstract available

  7. LIU Y, Xiao X, Yang Y, Yao R, et al
    The risk of Alzheimer's disease and cognitive impairment characteristics in eight mental disorders: A UK Biobank observational study and Mendelian randomization analysis.
    Alzheimers Dement. 2024 Jun 11. doi: 10.1002/alz.14049.
    PubMed         Abstract available

  8. DING X, Yin L, Zhang L, Zhang Y, et al
    Diabetes accelerates Alzheimer's disease progression in the first year post mild cognitive impairment diagnosis.
    Alzheimers Dement. 2024 Jun 12. doi: 10.1002/alz.13882.
    PubMed         Abstract available

  9. BERRON D, Olsson E, Andersson F, Janelidze S, et al
    Remote and unsupervised digital memory assessments can reliably detect cognitive impairment in Alzheimer's disease.
    Alzheimers Dement. 2024 Jun 12. doi: 10.1002/alz.13919.
    PubMed         Abstract available

    Biol Psychiatry

  10. HUO Y, Jing R, Li P, Chen P, et al
    Delineating the Heterogeneity of Alzheimer's Disease and Mild Cognitive Impairment Using Normative Models of the Dynamic Brain Functional Networks.
    Biol Psychiatry. 2024 Jun 8:S0006-3223(24)01365.
    PubMed         Abstract available

    BMC Neurol

  11. ZHU W, Zhou X, Ren M, Yin W, et al
    Process approach as a cognitive biomarker related to gray matter volume in mild cognitive impairment and Alzheimer's disease.
    BMC Neurol. 2024;24:199.
    PubMed         Abstract available

    Brain Res

  12. MCCLARTY BM, Rodriguez G, Dong H
    Class 1 histone deacetylases differentially modulate memory and synaptic genes in a spatial and temporal manner in aged and APP/PS1 mice.
    Brain Res. 2024;1837:148951.
    PubMed         Abstract available

  13. WANG Y, Wu LH, Hou F, Wang ZJ, et al
    Mitochondrial calcium uniporter knockdown in hippocampal neurons alleviates anxious and depressive behavior in the 3XTG Alzheimer's disease mouse model.
    Brain Res. 2024 Jun 6:149060. doi: 10.1016/j.brainres.2024.149060.
    PubMed         Abstract available

  14. RUSSO ML, Ayala G, Neal D, Rogalsky AE, et al
    Alzheimer's-linked axonal changes accompany elevated antidromic action potential failure rate in aged mice.
    Brain Res. 2024 Jun 10:149083. doi: 10.1016/j.brainres.2024.149083.
    PubMed         Abstract available

    Dement Geriatr Cogn Disord

  15. CHO BH, Kim H, Choi SM, Cho SH, et al
    Differences in cognitive trajectories of dementia: Comparison Alzheimer's disease dementia and Dementia with Lewy bodies in Korean patient cohort.
    Dement Geriatr Cogn Disord. 2024 Jun 8. doi: 10.1159/000539743.
    PubMed         Abstract available

    J Alzheimers Dis

  16. SUGANUMA T, Hatori S, Chen CK, Hori S, et al
    Caffeoylquinic Acid Mitigates Neuronal Loss and Cognitive Decline in 5XFAD Mice Without Reducing the Amyloid-beta Plaque Burden.
    J Alzheimers Dis. 2024;99:1285-1301.
    PubMed         Abstract available

  17. FUKUI Y, Tadokoro K, Hamada M, Asada K, et al
    A Novel Peptidome Technology for the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease by Selected Reaction Monitoring.
    J Alzheimers Dis. 2024 Jun 1. doi: 10.3233/JAD-230915.
    PubMed         Abstract available

  18. LIANG X, Wang Y, Li S, Fan J, et al
    Enhancing Rab7 Activity by Inhibiting TBC1D5 Expression Improves Mitophagy in Alzheimer's Disease Models.
    J Alzheimers Dis. 2024 Jun 1. doi: 10.3233/JAD-231300.
    PubMed         Abstract available

  19. TAVARES-JUNIOR JWL, Ciurleo GCV, Feitosa EAAF, Oria RB, et al
    The Clinical Aspects of COVID and Alzheimer's Disease: A Round-Up of Where Things Stand and Are Headed.
    J Alzheimers Dis. 2024;99:1159-1171.
    PubMed         Abstract available

  20. TAYLOR J, Jaros M, Chen C, Harrison J, et al
    Plasma pTau181 Predicts Clinical Progression in a Phase 2 Randomized Controlled Trial of the 11beta-HSD1 Inhibitor Xanamem(R) for Mild Alzheimer's Disease.
    J Alzheimers Dis. 2024 May 31. doi: 10.3233/JAD-231456.
    PubMed         Abstract available

  21. LI D, Xie Q, Xie J, Ni M, et al
    Cerebrospinal Fluid Proteomics Identifies Potential Biomarkers for Early-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jun 5. doi: 10.3233/JAD-240022.
    PubMed         Abstract available

  22. CANTERO-FORTIZ Y, Cano A, Boada M
    Unraveling the Tau Puzzle: A Brief Discussion on Biomarkers in Alzheimer's Disease.
    J Alzheimers Dis. 2024 May 30. doi: 10.3233/JAD-240055.
    PubMed         Abstract available

  23. SUN CK, Guo F, Ou YN, Zhang MZ, et al
    Association Between Carotid Plaque and Alzheimer's Disease Cerebrospinal Fluid Biomarkers and Cognitive Function in Cognitively Intact Adults: The CABLE Study.
    J Alzheimers Dis. 2024 Jun 1. doi: 10.3233/JAD-240131.
    PubMed         Abstract available

  24. CHEN YH, Wang ZB, Liu XP, Mao ZQ, et al
    Plasma Insulin Predicts Early Amyloid-beta Pathology Changes in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jun 5. doi: 10.3233/JAD-240289.
    PubMed         Abstract available

  25. LI JG, Mutreja Y, Servili M, Leone A, et al
    The Anti-Neuroinflammatory Effect of Extra-Virgin Olive Oil in the Triple Transgenic Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jun 4. doi: 10.3233/JAD-240374.
    PubMed         Abstract available

  26. Erratum to: Self-Reported Late-Life Hypertension Is Associated with a Healthy Cognitive Status and Reduced Alzheimer's Disease Pathology Burden.
    J Alzheimers Dis. 2024 Jun 3. doi: 10.3233/JAD-249010.

  27. DESAI S, Chen IY, Hom C, Doran E, et al
    Insomnia Symptoms Are Associated with Measures of Functional Deterioration and Dementia Status in Adults with Down Syndrome at High Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jun 14. doi: 10.3233/JAD-220750.
    PubMed         Abstract available

  28. CHANDLER JM, Ye W, Mi X, Doty EG, et al
    Potential Impact of Slowing Disease Progression in Early Symptomatic Alzheimer's Disease on Patient Quality of Life, Caregiver Time, and Total Societal Costs: Estimates Based on Findings from GERAS-US Study.
    J Alzheimers Dis. 2024 Jun 8. doi: 10.3233/JAD-231166.
    PubMed         Abstract available

  29. CHEN X, Walton K, Brodaty H, Chalton K, et al
    Polyphenols and Diets as Current and Potential Nutrition Senotherapeutics in Alzheimer's Disease: Findings from Clinical Trials.
    J Alzheimers Dis. 2024 Jun 12. doi: 10.3233/JAD-231222.
    PubMed         Abstract available

  30. LALIVE HM, Griffa A, Carlier S, Nasuti M, et al
    Amnestic Syndrome in Memory Clinics: Similar Morphological Brain Patterns in Older Adults with and without Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jun 7. doi: 10.3233/JAD-240026.
    PubMed         Abstract available

  31. CABALLERO HS, McFall GP, Gee M, MacDonald S, et al
    Cognitive Speed in Neurodegenerative Disease: Comparing Mean Rate and Inconsistency Within and Across the Alzheimer's and Lewy Body Spectra in the COMPASS-ND Study.
    J Alzheimers Dis. 2024 Jun 12. doi: 10.3233/JAD-240210.
    PubMed         Abstract available

  32. SHAMSI A, Furkan M, Khan MS, Yadav DK, et al
    Computational Screening of Repurposed Drugs for HMG-CoA Synthase 2 in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Jun 8. doi: 10.3233/JAD-240376.
    PubMed         Abstract available

  33. CANDEIAS E, Pereira-Santos AR, Empadinhas N, Cardoso SM, et al
    The Gut-Brain Axis in Alzheimer's and Parkinson's Diseases: The Catalytic Role of Mitochondria.
    J Alzheimers Dis. 2024 Jun 8. doi: 10.3233/JAD-240524.
    PubMed         Abstract available

  34. WANG T, Zhang W, Maclin JMA, Xu H, et al
    Novel Panel of Long Noncoding RNAs as Diagnostic Biomarkers for Amnestic Mild Cognitive Impairment in Peripheral Blood.
    J Alzheimers Dis. 2024;99:1385-1396.
    PubMed         Abstract available

  35. XIONG R, Li B, Yu H, Fan T, et al
    Urolithin A Inhibits Anterior Basolateral Amygdala to Ventral Hippocampal CA1 Circuit to Ameliorate Amyloid-beta-Impaired Social Ability.
    J Alzheimers Dis. 2024;99:1303-1316.
    PubMed         Abstract available

    J Neurol Neurosurg Psychiatry

  36. DOBSON R, Patterson K, Malik R, Mandal U, et al
    Eligibility for antiamyloid treatment: preparing for disease-modifying therapies for Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2024 Jun 11:jnnp-2024-333468.
    PubMed         Abstract available

    Predicting how many people might receive treatment with new therapies for Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2024 Jun 11:jnnp-2024-333941.

    J Neurosci

  38. MURAKAMI R, Watanabe H, Hashimoto H, Kashiwagi-Hakozaki M, et al
    Inhibitory roles of Apolipoprotein E Christchurch astrocytes in curbing tau propagation using human pluripotent stem cell-derived models.
    J Neurosci. 2024 Apr 22:e1709232024. doi: 10.1523/JNEUROSCI.1709-23.2024.
    PubMed         Abstract available

    Nat Rev Neurol

  39. MIELKE MM, Fowler NR
    Alzheimer disease blood biomarkers: considerations for population-level use.
    Nat Rev Neurol. 2024 Jun 11. doi: 10.1038/s41582-024-00989.
    PubMed         Abstract available

  40. SCHINDLER SE, Galasko D, Pereira AC, Rabinovici GD, et al
    Acceptable performance of blood biomarker tests of amyloid pathology - recommendations from the Global CEO Initiative on Alzheimer's Disease.
    Nat Rev Neurol. 2024 Jun 12. doi: 10.1038/s41582-024-00977.
    PubMed         Abstract available


  41. GRAHAM F
    Daily briefing: Landmark Alzheimer's paper will be retracted.
    Nature. 2024 Jun 5. doi: 10.1038/d41586-024-01699.

    Alzheimer's drug with modest benefits wins backing of FDA advisers.
    Nature. 2024 Jun 10. doi: 10.1038/d41586-024-01726.

    Neurobiol Aging

  43. CAVALLARI M, Touroutoglou A, Katsumi Y, Fong TG, et al
    Relationship between cortical brain atrophy, delirium, and long-term cognitive decline in older surgical patients.
    Neurobiol Aging. 2024;140:130-139.
    PubMed         Abstract available

  44. LIBRI I, Silvestri C, Caratozzolo S, Alberici A, et al
    Association of APOE genotype with blood-brain barrier permeability in neurodegenerative disorders.
    Neurobiol Aging. 2024;140:33-40.
    PubMed         Abstract available


  45. MASTENBROEK SE, Sala A, Vallez Garcia D, Shekari M, et al
    Continuous beta-Amyloid CSF/PET Imbalance Model to Capture Alzheimer Disease Heterogeneity.
    Neurology. 2024;103:e209419.
    PubMed         Abstract available

  46. HAMILTON CA, Donaghy PC, Durcan R, Ciafone J, et al
    Outcomes of Patients With Mild Cognitive Impairment With Lewy Bodies or Alzheimer Disease at 3 and 5 Years After Diagnosis.
    Neurology. 2024;103:e209499.
    PubMed         Abstract available

    Neurosci Lett

  47. SMITH AS, Subramanian J, Doderer J, Moskovitz J, et al
    Methionine oxidation of clusterin in Alzheimer's disease and its effect on clusterin's binding to beta-amyloid.
    Neurosci Lett. 2024;836:137874.
    PubMed         Abstract available

  48. CHITTORA R, Jain S, Roy A, Pandey S, et al
    Multifactorial effects of short duration early exposure low intensity magnetic field stimulation in Streptozotocin induced Alzheimer's disease rat model.
    Neurosci Lett. 2024;836:137878.
    PubMed         Abstract available


  49. AHMAD RATHER M, Khan A, Jahan S, Jamal Siddiqui A, et al
    Influence of Tau on neurotoxicity and cerebral vasculature impairment associated with Alzheimer's disease.
    Neuroscience. 2024 Jun 11:S0306-4522(24)00252.
    PubMed         Abstract available

    PLoS One

  50. LIAO K, Lou Q
    Alzheimer's disease increases the risk of erectile dysfunction independent of cardiovascular diseases: A mendelian randomization study.
    PLoS One. 2024;19:e0303338.
    PubMed         Abstract available

  51. SANO M, Nishiura Y, Morikawa I, Hoshino A, et al
    Analysis of the alpha activity envelope in electroencephalography in relation to the ratio of excitatory to inhibitory neural activity.
    PLoS One. 2024;19:e0305082.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  52. AXELL E, Hu J, Lindberg M, Dear AJ, et al
    The role of shear forces in primary and secondary nucleation of amyloid fibrils.
    Proc Natl Acad Sci U S A. 2024;121:e2322572121.
    PubMed         Abstract available


    New Alzheimer's drug clears FDA advisory vote despite unknowns.
    Science. 2024;384:1164-1165.
    PubMed         Abstract available

  54. PARK J, Wang J, Guan W, Gjesteby LA, et al
    Integrated platform for multiscale molecular imaging and phenotyping of the human brain.
    Science. 2024;384:eadh9979.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.